The R.E.N.A.L score's relevance in determining perioperative and oncological outcomes: a Middle-Eastern tertiary care center experience.

IF 1.3 Q3 UROLOGY & NEPHROLOGY Arab Journal of Urology Pub Date : 2022-04-17 eCollection Date: 2022-01-01 DOI:10.1080/2090598X.2022.2064041
Nassib Abou Heidar, Nizar Hakam, Jose M El-Asmar, Jad Najdi, Mark A Khauli, Jad Degheili, Albert El-Hajj, Rami Nasr, Wassim Wazzan, Muhammad Bulbul, Deborah Mukherji, Raja Khauli
{"title":"The R.E.N.A.L score's relevance in determining perioperative and oncological outcomes: a Middle-Eastern tertiary care center experience.","authors":"Nassib Abou Heidar,&nbsp;Nizar Hakam,&nbsp;Jose M El-Asmar,&nbsp;Jad Najdi,&nbsp;Mark A Khauli,&nbsp;Jad Degheili,&nbsp;Albert El-Hajj,&nbsp;Rami Nasr,&nbsp;Wassim Wazzan,&nbsp;Muhammad Bulbul,&nbsp;Deborah Mukherji,&nbsp;Raja Khauli","doi":"10.1080/2090598X.2022.2064041","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to evaluate the significance of the R.E.N.A.L nephrometry scoring system in predicting perioperative and oncological outcomes and determining the surgical approach of choice for kidney tumors.Patients and Methods: Our study retrospectively reviewed outcomes from the year 2002 to 2017. Mann-Whitney U test was used to compare continuous variables and chi-square test was used to compare categorical variables. Kaplan-Meier estimates and multivariable cox proportional hazard regression were performed to determine an association between the different R.E.N.A.L categories and disease recurrence or mortality.</p><p><strong>Results: </strong>A total of 325 patients underwent kidney surgery The most common R.E.N.A.L score category in our cohort study was intermediate (41.2%), followed by low, (33.2%) and high (25.5%). Patients with a high R.E.N.A.L score had worse perioperative outcomes compared to those with a low R.E.N.A.L score. High R.E.N.A.L score patients were 3 times more likely to receive blood transfusions compared to those with a low R.E.N.A.L score (19.4% vs 6.3%, p = 0.018), and a statistically significant longer hospital length of stay was also observed between the two groups (median 4.5 vs 4 days, p = 0.0419). In addition, the only predictor of disease recurrence or mortality was a high R.E.N.A.L score (Hazard Ratio (HR) 3.65, 95% Confidence Interval (CI) 1.05-12.7, p = 0.041).</p><p><strong>Conclusion: </strong>Our study sheds light on the use of R.E.N.A.L nephrometry score in predicting perioperative, postoperative, and oncological outcomes. Such findings may play a role in optimizing surgical approaches and pre-operative patient counseling.</p>","PeriodicalId":8113,"journal":{"name":"Arab Journal of Urology","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2022-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354629/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arab Journal of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/2090598X.2022.2064041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Objective: The aim of this study is to evaluate the significance of the R.E.N.A.L nephrometry scoring system in predicting perioperative and oncological outcomes and determining the surgical approach of choice for kidney tumors.Patients and Methods: Our study retrospectively reviewed outcomes from the year 2002 to 2017. Mann-Whitney U test was used to compare continuous variables and chi-square test was used to compare categorical variables. Kaplan-Meier estimates and multivariable cox proportional hazard regression were performed to determine an association between the different R.E.N.A.L categories and disease recurrence or mortality.

Results: A total of 325 patients underwent kidney surgery The most common R.E.N.A.L score category in our cohort study was intermediate (41.2%), followed by low, (33.2%) and high (25.5%). Patients with a high R.E.N.A.L score had worse perioperative outcomes compared to those with a low R.E.N.A.L score. High R.E.N.A.L score patients were 3 times more likely to receive blood transfusions compared to those with a low R.E.N.A.L score (19.4% vs 6.3%, p = 0.018), and a statistically significant longer hospital length of stay was also observed between the two groups (median 4.5 vs 4 days, p = 0.0419). In addition, the only predictor of disease recurrence or mortality was a high R.E.N.A.L score (Hazard Ratio (HR) 3.65, 95% Confidence Interval (CI) 1.05-12.7, p = 0.041).

Conclusion: Our study sheds light on the use of R.E.N.A.L nephrometry score in predicting perioperative, postoperative, and oncological outcomes. Such findings may play a role in optimizing surgical approaches and pre-operative patient counseling.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
R.E.N.A.L评分在确定围手术期和肿瘤预后中的相关性:中东三级护理中心的经验。
目的:本研究的目的是评估R.E.N.A.L肾测量评分系统在预测围手术期和肿瘤预后以及确定肾肿瘤手术入路选择方面的意义。患者和方法:我们的研究回顾性回顾了2002年至2017年的结果。连续变量比较采用Mann-Whitney U检验,分类变量比较采用卡方检验。采用Kaplan-Meier估计和多变量cox比例风险回归来确定不同R.E.N.A.L类别与疾病复发或死亡率之间的关系。结果:共有325例患者接受了肾脏手术。在我们的队列研究中,最常见的R.E.N.A.L评分类别是中等(41.2%),其次是低(33.2%)和高(25.5%)。与低R.E.N.A.L评分的患者相比,高R.E.N.A.L评分的患者围手术期预后更差。高R.E.N.A.L评分患者接受输血的可能性是低R.E.N.A.L评分患者的3倍(19.4% vs 6.3%, p = 0.018),两组患者住院时间更长(中位数4.5 vs 4天,p = 0.0419)。此外,疾病复发或死亡的唯一预测因子是较高的R.E.N.A.L评分(风险比(HR) 3.65, 95%可信区间(CI) 1.05-12.7, p = 0.041)。结论:我们的研究阐明了R.E.N.A.L肾测量评分在预测围手术期、术后和肿瘤预后方面的应用。这些发现可能在优化手术入路和术前患者咨询方面发挥作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Arab Journal of Urology
Arab Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
2.80
自引率
0.00%
发文量
40
期刊介绍: The Arab Journal of Urology is a peer-reviewed journal that strives to provide a high standard of research and clinical material to the widest possible urological community worldwide. The journal encompasses all aspects of urology including: urological oncology, urological reconstructive surgery, urodynamics, female urology, pediatric urology, endourology, transplantation, erectile dysfunction, and urinary infections and inflammations. The journal provides reviews, original articles, editorials, surgical techniques, cases reports and correspondence. Urologists, oncologists, pathologists, radiologists and scientists are invited to submit their contributions to make the Arab Journal of Urology a viable international forum for the practical, timely and state-of-the-art clinical urology and basic urological research.
期刊最新文献
Idiopathic male infertility – what are we missing? Do mobile phones and laptop computers really impact sperm? Efficacy and safety of office-based diode laser ablation for recurrent low-grade non-muscle-invasive bladder cancer under local anaesthesia: A pilot study Posterior tibial nerve stimulation versus desmopressin in treating children with primary mono-symptomatic nocturnal enuresis. A randomized clinical trial “Laser vaporization of the prostate: A comparative study between ejaculatory preserving and non-ejaculatory preserving technique”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1